-
The currency problem perhaps has its roots partially in the high current account deficit and partially in the likelihood of tapering of the QE by the US
We may see the market bottom within 3 months Amid…
Read more -
Ajanta Pharma in ‘Forbes Asia’s 200 Best under a Billion’ list
Ajanta Pharma, a Rs.900 crore plus specialty focused pharmaceutical formulation company…
Read more -
Nilesh Gupta Sets Target at $5 billion by 2018
“I’ll be 40 soon,” quipped 39-year-old Nilesh Gupta, who takes…
Read more -
Habil Khorakiwala in Panic as Chikalthana plant Report is awaited!
An FDA import alert can cause Rs 1,200 cr loss…
Read more -
Clinical Trials India is in Danger?
The government must ensure ethical clinical trials, a critical part…
Read more -
Indian Pharma Policy makers lapse create shortage of essential medicines
MUMBAI: A shortage of essential medicines is looming across major…
Read more -
Sharma says govt looking at concerns over FDI in pharmaCommerce and Industry Ministry has also raised serious concerns over the spate of mergers and acquisitions of Indian pharma companies. ‘Negative narrative’ cast adverse impact on economy:
Government is looking at concerns raised by many over FDI…
Read more -
India pharma companies should follow strict regulations: FDA
Washington: The Food and Drug Administration (FDA) is not singling…
Read more -
Indian Pharma Sector is today Directionless from Govt!
Mylan, the third largest generic pharmaceuticals company in the world,…
Read more -
The DIPP is in favour of restrictions on at least three categories of pharmaceuticals – vaccines, injectibles and oncology (cancer) medicines.
The Industry Department (DIPP) is proposing to extend restrictions on…
Read more